Hagiwara T, Sugimoto K, Momose H, Irie T, et al. CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer. Anticancer Res 2022;42:697-707.
PMID: 35093868